Dear Colleagues:

I am honored to be writing to you as your new CIS President. Kate Sullivan has provided superb leadership over the past year, and CIS has undergone exciting change and growth. Let me summarize what has been accomplished.

In December, the CIS Council held a strategic planning session to consider how CIS and its membership could propel the growing role of immunology in understanding of organ-specific diseases, and the enormous potential of immunologic therapies. The new initiatives and priorities as outlined by the Council include:

• Increase retention of trainees
• Develop additional clinical programs at meetings
• Expand web-based educational resources for the broader community
• Develop additional summer schools on immunologically relevant topics
• Create a home for immunodeficiency
• Create a forum for Phase I correlative and mechanism of action research studies.

Click here to read more . . .